Tom Fernandez is a founder of Balto Therapeutics, a specialty pharmaceutical company in New York. Previously, he co-founded Retrophin, Inc., a public biopharmaceutical company focused on discovering, developing and marketing innovative therapies for rare, catastrophic childhood diseases. Before that, he was a partner at a family of hedge funds, Galleon Group, where he led Investor Relations and the global marketing effort. Prior to Galleon, Tom was Assistant Dean for MBA Career Services and Director of The Chazen Institute of International Business at Columbia Business School. He is a member of the advisory board of Equity for Children, a nonprofit organisation that strives to advance an agenda of social justice, human rights and social equality for children worldwide. Tom holds a BA in History from Yale University and an MBA from The Wharton School, University of Pennsylvania.